Cite
HARVARD Citation
Wollenberg, A. et al. (2021). Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial. Journal of the European Academy of Dermatology and Venereology. pp. 1543-1552. [Online].